A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

Last updated:
2026-10-03
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO INVESTIGATE THE EFFECT OF ORFORGLIPRON ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PARTICIPANTS WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND/OR CHRONIC KIDNEY DISEASE (ATTAIN-OUTCOMES)

Intervention/treatment:
ORFORGLIPRON (LY3502970)
Medical condition:
CARDIOVASCULAR DISEASE
Protocol code:
J2A-MC-GZPW
Control number:
301085
Status:
Recruiting
Approved:
September 22, 2025
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT07241390
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
50 Years and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
Role
CONTACT
Phone:
317-615-4559
Name
Physicians interested in becoming principal investigators please contact
Role
CONTACT
Sponsor
ELI LILLY CANADA INC

Locations

Applied Medical Informatics Research
Montreal, H4A 3T2
Recruiting
Name
Michael Tsoukas
Role
PRINCIPAL_INVESTIGATOR
Phone:
514-938-0995
Bluewater Clinical Research Group Inc.
Sarnia, N7T 4X3
Recruiting
Name
Justin Rayes
Role
CONTACT
Phone:
1 (519) 344-6612
Name
John O'Mahony
Role
PRINCIPAL_INVESTIGATOR
C.I.C. Mauricie inc.
Trois Rivieres, G8T 7A1
Recruiting
Name
Pierre-Alexandre Menard
Role
PRINCIPAL_INVESTIGATOR
Cambridge Cardiac Care Centre
Cambridge, N1R 6V6
Recruiting
Role
CONTACT
Phone:
5196243511
Name
A. Shekhar Pandey
Role
PRINCIPAL_INVESTIGATOR
Centricity Research Brampton Endocrinology
Brampton, L6S 0C6
Recruiting
Role
CONTACT
Phone:
905 595 0560
Name
Harpreet Bajaj
Role
PRINCIPAL_INVESTIGATOR
CHU de Quebec - Université Laval - Hotel Dieu de Quebec
Quebec, G1R 2J6
Recruiting
Name
Mohsen Agharazii
Role
PRINCIPAL_INVESTIGATOR
Clinical Research Solutions - Kitchener
Waterloo, N2T 0C1
Recruiting
Role
CONTACT
Phone:
519 743 2573
Name
Shivinder Jolly
Role
PRINCIPAL_INVESTIGATOR
Diex Recherche Inc. Division Quebec
Quebec, G1V 4T3
Recruiting
Name
Marie-Philippe Morin
Role
PRINCIPAL_INVESTIGATOR
Diex Recherche Inc. Division Trois-Rivieres
Trois Rivieres, G9A 4P3
Recruiting
Role
CONTACT
Phone:
819-801-9797
Name
Ying Sia
Role
PRINCIPAL_INVESTIGATOR
Ecogene-21
Chicoutimi, G7H 7K9
Recruiting
Role
CONTACT
Phone:
418-545-1252
Name
Daniel Gaudet
Role
PRINCIPAL_INVESTIGATOR
G A Research Associates
Moncton, E1G 1A7
Recruiting
Role
CONTACT
Phone:
506-852-9865
Name
Jocelyn Cormier
Role
PRINCIPAL_INVESTIGATOR
Glanz Medicine Professional Corporation
Windsor, N8X 5A6
Recruiting
Role
CONTACT
Phone:
5192545726
Name
Anthony Glanz
Role
PRINCIPAL_INVESTIGATOR
Heart Health Institute - Scarborough Office
Scarborough, M1B 4Z8
Recruiting
Name
Andrew Yadegari
Role
PRINCIPAL_INVESTIGATOR
Phone:
1 (519) 344-6612
Kidney Care Centre - Surrey
Surrey, V3W 1J8
Recruiting
Name
Micheli Bevilacqua
Role
PRINCIPAL_INVESTIGATOR
Premier Clinical Trial Network
Hamilton, L8L 5G4
Recruiting
Role
CONTACT
Phone:
905 407 8945
Name
Richard Tytus
Role
PRINCIPAL_INVESTIGATOR
Seven Oaks General Hospital
Winnipeg, R2V 3M3
Recruiting
Name
Navdeep Tangri
Role
PRINCIPAL_INVESTIGATOR
THEO Medical Concorde
Laval, H7G 2E6
Recruiting
Role
CONTACT
Phone:
438-320-7171
Name
Naim Ben Yedder
Role
PRINCIPAL_INVESTIGATOR
The Wharton Medical Clinic Clinical Trials Inc
Hamilton, L8L 5G8
Recruiting
Role
CONTACT
Phone:
1-905-523-8134 Ext. 274
Name
Sean Wharton
Role
PRINCIPAL_INVESTIGATOR
Winchester District Memorial Hospital
Winchester, K0C 2K0
Recruiting
Role
CONTACT
Phone:
613-774-2420 ext 6211
Name
Rimon Ghattas
Role
PRINCIPAL_INVESTIGATOR
Did you find what you were looking for?

Contacts and resources